Challenge in hyponatremic patients – the potential of a laboratory-based decision support system for hyponatremia to improve patient’s safety
Clinical Chemistry and Laboratory Medicine (CCLM) · 25.05.2023 · 61 (6) · 1025-1034
DOI: 10.1515/cclm-2022-0883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Chemistry and Laboratory Medicine (CCLM), online erschienen am 04.01.2023. Verfasst von Tom Sicker und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics, University of Leipzig Medical Center, Leipzig, Germany. Hauptthemen laut MEDLINE: Hyponatremia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Hyponatremia is the most frequent electrolyte disorder in hospitalized patients with increased mortality and morbidity. In this study, we evaluated the follow-up diagnostic, the risk of inadequate fast correction and the outcome of patients with profound hyponatremia (pHN), defined as a blood sodium concentration below 120 mmol/L. The aim was to identify a promising approach for a laboratory-based clinical decision support system (CDSS).
Methods
This retrospective study included 378,980 blood sodium measurements of 83,315 cases at a German tertiary care hospital. Hospitalized cases with pHN (n=211) were categorized into two groups by the time needed for a follow-up measurement to be performed (time to control, TTC) as either 12 h (group 2: “TTC>12 h”, n=93 cases). Length of hospital stay, sodium level at discharge, ward transfers, correction of hyponatremia, and risk of osmotic demyelination syndrome (ODS) due to inadequate fast correction were evaluated with regard to the TTC of sodium blood concentration. Results pHN was detected in 1,050 measurements (0.3%) in 211 cases. Cases, in which follow-up diagnostics took longer (TTC>12 h), achieved a significantly lower sodium correction during their hospitalization (11.2 vs. 16.7 mmol/L, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Laboratory Medicine, Clinical Chemistry, and Molecular Diagnostics, University of Leipzig Medical Center, Leipzig, Germany.
- Department of Endocrinology, Diabetes, and Metabolism, University Hospital Bonn, Bonn, Germany.
- Institute for Laboratory Medicine, Microbiology and Pathobiochemistry, University Hospital Ostwestfalen-Lippe, Lippe, Germany.
Zitieren
APA
Sicker, T., Federbusch, M., Eckelt, F., Isermann, B., Fenske, W., Fries, C., Schmidt, M., & Kaiser, T. (2023). Challenge in hyponatremic patients – the potential of a laboratory-based decision support system for hyponatremia to improve patient’s safety. Clinical Chemistry and Laboratory Medicine (CCLM), 61(6), 1025-1034. https://doi.org/10.1515/cclm-2022-0883
Vancouver
Sicker T, Federbusch M, Eckelt F, Isermann B, Fenske W, Fries C, et al. Challenge in hyponatremic patients – the potential of a laboratory-based decision support system for hyponatremia to improve patient’s safety. Clinical Chemistry and Laboratory Medicine (CCLM). 2023;61(6):1025-1034. doi:10.1515/cclm-2022-0883
BibTeX
@article{Sicker2023,
author = {Sicker, Tom and Federbusch, Martin and Eckelt, Felix and Isermann, Berend and Fenske, Wiebke and Fries, Charlotte and Schmidt, Maria and Kaiser, Thorsten},
title = {Challenge in hyponatremic patients – the potential of a laboratory-based decision support system for hyponatremia to improve patient’s safety},
journal = {Clinical Chemistry and Laboratory Medicine (CCLM)},
year = {2023},
volume = {61},
number = {6},
pages = {1025--1034},
doi = {10.1515/cclm-2022-0883}
}
EUVIMED